Severe heart disease in an unusual case of familial amyloid polyneuropathy type I

Pettersson, 2010, Amyloidosis—recent developments, Semin Arthritis Rheum, 39, 356, 10.1016/j.semarthrit.2008.09.001 Falk, 2010, Amyloid heart disease, Prog Cardiovasc Dis, 52, 347, 10.1016/j.pcad.2009.11.007 Hirschfield, 2004, Amyloidosis: a clinico-pathophysiological synopsis, Semin Cell Dev Biol, 15, 39, 10.1016/j.semcdb.2003.12.013 Garcia-Pavia, 2011, Amyloidosis. Also a heart disease, Rev Esp Cardiol, 64, 797 Rapezzi, 2009, Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types, Circulation, 120, 1203, 10.1161/CIRCULATIONAHA.108.843334 Hachulla, 2002, Diagnostic tools for amyloidosis, Joint Bone Spine, 69, 538, 10.1016/S1297-319X(02)00449-9 Selvanayagam, 2007, Evaluation and management of the cardiac amyloidosis, J Am Coll Cardiol, 50, 2101, 10.1016/j.jacc.2007.08.028 Tsuchiya-Suzuki, 2011, Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin val30met, Hum Pathol, 42, 236, 10.1016/j.humpath.2010.06.014 Koike, 2009, Distinct characteristics of amyloid deposits in early- and late-onset transthyretin val30met familial amyloid polyneuropathy, J Neurol Sci, 287, 178, 10.1016/j.jns.2009.07.028 Ando, 2005, Transthyretin-related familial amyloidotic polyneuropathy, Arch Neurol, 62, 1057, 10.1001/archneur.62.7.1057 Andrade, 1952, A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves, Brain, 75, 408, 10.1093/brain/75.3.408 Olsson, 2010, 1 Rudolph, 2008, Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history, Clin Med Res, 6, 80, 10.3121/cmr.2008.794 Conceicao, 2007, Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal, Muscle Nerve, 35, 116, 10.1002/mus.20644 Hornsten, 2010, Heart complications in familial transthyretin amyloidosis: impact of age and gender, Amyloid, 17, 63, 10.3109/13506129.2010.483114 Suhr, 2008, Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?, J Intern Med, 263, 294, 10.1111/j.1365-2796.2007.01888.x Anzai, 1989, Treatment by pacemaker in familial amyloid polyneuropathy, Chest, 96, 80, 10.1378/chest.96.1.80 de Freitas, 1986, The heart in Portuguese amyloidosis, Postgrad Med J, 62, 601, 10.1136/pgmj.62.728.601 Eriksson, 1984, Disturbances of cardiac rhythm and conduction in familial amyloidosis with polyneuropathy, Br Heart J, 51, 658, 10.1136/hrt.51.6.658 Eriksson, 1984, The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden, Virchows Arch A Pathol Anat Histopathol, 402, 239, 10.1007/BF00695078 Coelho, 1961, Cardiac involvement in a peculiar form of paramyloidosis, Am J Cardiol, 8, 624, 10.1016/0002-9149(61)90365-4 Hornsten, 2006, Ventricular late potentials in familial amyloidotic polyneuropathy, J Electrocardiol, 39, 57, 10.1016/j.jelectrocard.2005.06.106 Wiklund, 2011, Irregular heart rate patterns during the deep breathing test in patients with familial amyloidotic polyneuropathy, J Electrocardiol, 44 Zhao, 2010, Left ventricular dyssynchrony is associated with reduced heart rate variability in familial amyloidotic polyneuropathy, Int J Cardiol, 1 Delahaye, 2001, Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy, Circulation, 104, 2911, 10.1161/hc4901.100380 Coutinho, 2006, Envolvimento cardíaco na polineuropatia amiloidótica familiar, Sinapse, 6, 92 Eriksson, 1986, Cardiac arrhythmias in familial amyloid polyneuropathy during anaesthesia, Acta Anaesthesiol Scand, 30, 317, 10.1111/j.1399-6576.1986.tb02422.x Kapoor, 2011, Cardiac amyloidosis: a practical approach to diagnosis and management, Am J Med, 124, 1006, 10.1016/j.amjmed.2011.04.013 Rapezzi, 2011, Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis, JACC Cardiovasc Imaging, 4, 659, 10.1016/j.jcmg.2011.03.016 Lindqvist, 2006, Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathy, Eur J Echocardiogr, 7, 22, 10.1016/j.euje.2005.03.004 Tanaka, 1997, Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy, J Am Coll Cardiol, 29, 168, 10.1016/S0735-1097(96)00438-X Okamoto, 2011, Continuous development of arrhythmia is observed in Swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant), Liver Transplant, 17, 122, 10.1002/lt.22184 Wiklund, 2010, Cardiac autonomic function does not improve after liver transplantation for familial amyloidotic polyneuropathy, Auton Neurosci, 156, 124, 10.1016/j.autneu.2010.04.007 Yazaki, 2007, Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients, Am J Transplant, 7, 235, 10.1111/j.1600-6143.2006.01585.x Hornsten, 2004, Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy. Portuguese-type (ATTR Val30Met) patients, Transplantation, 78, 112, 10.1097/01.TP.0000133517.20972.27 Olofsson, 2002, Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese Type Transplant, 73, 745 Yazaki, 2000, Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin, Biochem Biophys Res Commun, 274, 702, 10.1006/bbrc.2000.3203 Coelho, 2010, Tafamidis (Fx-1006A): a first-in-class disease-modifying therapy for transthyretin type familial amyloid polyneuropathy, Neurology, 74, A286 Bourgault, 2011, Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs, Biochem Biophys Res Commun, 410, 707, 10.1016/j.bbrc.2011.04.133 Macedo, 2010, Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model, Pharmacol Res, 62, 514, 10.1016/j.phrs.2010.08.001 Cardoso, 2006, Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model, FASEB J, 20, 234, 10.1096/fj.05-4509com Tanaka, 2001, Suppression of transthyretin expression by ribozymes: a possible therapy for familial amyloidotic polyneuropathy, J Neurol Sci, 183, 79, 10.1016/S0022-510X(00)00481-0